Maplight Therapeutics Inc (MPLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | |
| Operating Expenses | 20,894 |
| Operating Income | -20,894 |
| Other Income | 1,878 |
| Pre-tax Income | -19,016 |
| Net Income Continuous | -19,016 |
| Net Income | $-19,016 |
| EPS Basic Total Ops | -25.08 |
| EPS Basic Continuous Ops | -25.08 |
| EPS Diluted Total Ops | -25.08 |
| EPS Diluted Continuous Ops | -25.08 |
| EBITDA(a) | $-20,894 |